| Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome |
26 |
| Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis |
19 |
| A multicentre validation study for the EU-TIRADS using histological diagnosis as a gold standard |
17 |
| The cortisol stress response induced by surgery: A systematic review and meta-analysis |
15 |
| Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews |
14 |
| Long-term safety of growth hormoneA combined registry analysis |
14 |
| Hypogonadism and male obesity: Focus on unresolved questions |
14 |
| Mortality data from the European Adrenal Insufficiency RegistryPatient characterization and associations |
13 |
| Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS |
13 |
| The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review |
12 |
| Antibiotics, gut microbiome and obesity |
12 |
| Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas |
11 |
| Diagnostic approach to low-renin hypertension |
11 |
| Diagnosis and management of central diabetes insipidus in adults |
11 |
| Hyponatraemia in patients with community-acquired pneumonia; prevalence and aetiology, and natural history of SIAD |
11 |
| Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort |
10 |
| Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen |
10 |
| Impact of TSH during the first trimester of pregnancy on obstetric and foetal complications: Usefulness of 2.5 mIU/L cut-off value |
10 |
| The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis |
10 |
| Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS |
10 |
| Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients |
9 |
| Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses |
9 |
| Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules |
9 |
| Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature |
9 |
| Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: A retrospective study |
8 |
| Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis |
8 |
| New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR- miR-221 and miR-222 levels in the evolution of the disease |
8 |
| Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study |
8 |
| Fertility induction in hypogonadotropic hypogonadal men |
8 |
| Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis |
8 |
| Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis |
8 |
| Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study |
8 |
| Brown adipose tissue thermogenesis in polycystic ovary syndrome |
8 |
| Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone |
8 |
| The USP8 mutational status may predict long-term remission in patients with Cushing's disease |
8 |
| Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome |
8 |
| Management of adrenal emergencies in educated patients with adrenal insufficiencyA prospective study |
7 |
| Vitamin D and calcium supplementation, skeletal muscle strength and serum testosterone in young healthy adult males: Randomized control trial |
7 |
| Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence |
7 |
| Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age |
7 |
| Multidisciplinary management of refractory insulinomas |
7 |
| High risk of hypogonadism in young male cancer survivors |
7 |
| Clinical associations of maternal thyroid function with foetal brain development: Epidemiological interpretation and overview of available evidence |
7 |
| The incidence of endogenous Cushing's syndrome in the modern era |
7 |
| C-11-Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice |
7 |
| Reversible male hypogonadotropic hypogonadism due to energy deficit |
7 |
| Polycystic ovary syndrome and adverse pregnancy outcomes: Current state of knowledge, challenges and potential implications for practice |
6 |
| Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome |
6 |
| Urea treatment in fluid restriction-refractory hyponatraemia |
6 |
| Identifying and addressing osteoporosis knowledge gaps in women with premature ovarian insufficiency and early menopause: A mixed-methods study |
6 |
